Related Experiment Videos
Exploring the cause of early miscarriage with SNP-array analysis and karyotyping
Summary
Chromosomal abnormalities, particularly aneuploidies, are the primary cause of early miscarriage. Genetic analysis of products-of-conception (POC) and parental karyotyping aid in risk assessment for future pregnancies.
Area of Science:
- Reproductive genetics
- Cytogenetics
- Genomic medicine
Background:
- Recurrent miscarriage affects a significant number of couples, impacting reproductive outcomes.
- Identifying the genetic causes of miscarriage is crucial for effective risk assessment and counseling.
- Previous methods for analyzing miscarriage causes have limitations in detecting certain chromosomal abnormalities.
Purpose of the Study:
- To investigate the etiological factors of early miscarriage.
- To assess the utility of single nucleotide polymorphism (SNP) array and karyotyping in identifying chromosomal abnormalities in products-of-conception (POC).
- To provide genetic risk assessment for guiding subsequent pregnancies.
Main Methods:
- Analysis of 484 products-of-conception (POC) samples using single nucleotide polymorphism (SNP) array.
- Karyotyping or fluorescence in situ hybridization (FISH) analysis of parental peripheral blood samples.
- G-banding for detection of major chromosomal rearrangements in couples.
Main Results:
- Successful SNP-array analysis of 96.7% of fresh POC samples.
- A high rate of clinically significant chromosomal abnormalities (58.3%) was detected, including aneuploidy (43.4%), polyploidy (8.8%), and partial aneuploidy (3.6%).
- Embryonic chromosomal abnormalities increased significantly with maternal age over 35; 12 major chromosomal rearrangements were identified in couples.
Conclusions:
- Chromosome abnormalities are the leading cause of early miscarriage, with aneuploidies being the most frequent type.
- SNP array and karyotyping provide valuable genetic information for understanding miscarriage.
- These genetic analyses enable accurate risk assessment to guide future pregnancy management.